Department of Pharmaceutics, Faculty of Pharmacy, Universitas Hasanuddin, Makassar 90245, Indonesia.
Department of Pharmaceutics, Faculty of Pharmacy, Universitas Hasanuddin, Makassar 90245, Indonesia.
Int J Pharm. 2021 Jun 1;602:120623. doi: 10.1016/j.ijpharm.2021.120623. Epub 2021 Apr 21.
Itraconazole is a lipophilic drug, which limits its absorption for ocular administration. This study focused on the incorporation of itraconazole into nanocrystalline carrier system with stabilizer Pluronic® F127 and was further formulated into thermosensitive in situ ocular gel. Itraconazole nanocrystals (ITZ-NCs) were fabricated using media milling method with ultra-small-scale device. The obtained nanocrystals were observed to have a better in vitro activity against C. albicans (CA) compared to free itraconazole suspension in water. Furthermore, the optimization of the thermosensitive ocular gel formula was carried out with a central composite design, using three types of polymers, namely Pluronic® F127, Pluronic® F68, and hydroxypropyl methylcellulose (HPMC). After being dispersed into the optimized thermosensitive gel base, ITZ-NCs did not alter in terms of physical characteristics. Ex vivo ocularkinetic studies on infected porcine eye models showed a better profile of the optimized formula of thermosensitive in situ ocular gel when compared to standard gel base. Importantly, the ex vivo antifungal activity of these preparations was also increased, with a 93% decrease in the CA population observed after 48 h in infected porcine eye model. Altogether, this work has provided evidence of a novel approach in developing more advanced treatments for fungal keratitis.
伊曲康唑是一种亲脂性药物,限制了其眼部给药的吸收。本研究专注于将伊曲康唑纳入含有稳定剂泊洛沙姆 F127 的纳米晶体载体系统,并进一步将其制成温敏型原位眼用凝胶。使用超小型装置的介质研磨法制备伊曲康唑纳米晶体(ITZ-NCs)。与水相中的游离伊曲康唑混悬剂相比,所获得的纳米晶体显示出对白色念珠菌(CA)更好的体外活性。此外,使用中心复合设计对温敏型眼用凝胶配方进行了优化,使用了三种类型的聚合物,即泊洛沙姆 F127、泊洛沙姆 F68 和羟丙基甲基纤维素(HPMC)。将 ITZ-NCs 分散到优化的温敏凝胶基质中后,其物理特性没有变化。在感染猪眼模型的离体眼动力学研究中,与标准凝胶基质相比,优化的温敏原位眼用凝胶配方表现出更好的效果。重要的是,这些制剂的离体抗真菌活性也得到了提高,在感染猪眼模型中观察到 CA 群体在 48 小时后减少了 93%。总之,这项工作为开发治疗真菌性角膜炎的更先进治疗方法提供了新的思路。